体内
磷酸化
磷酸酶
化学
蛋白磷酸酶2
可药性
连环素
医学
癌症研究
药理学
内科学
纤维化
信号转导
Wnt信号通路
生物
生物化学
生物技术
基因
作者
Xiao Wei Zheng,Lu Wen,Dong Zeng,Dandan Yin,Xun Clare Zhou,Chengyuan Tang,Ying Li
出处
期刊:Inflammation
[Springer Science+Business Media]
日期:2020-01-15
卷期号:43 (3): 878-891
被引量:11
标识
DOI:10.1007/s10753-019-01173-0
摘要
Norcantharidin (NCTD) is a potential anti-renal interstitial fibrotic drug. However, the underlying molecular mechanism of how NCTD works remains unclear. In this study, using both in vivo and in vitro models, we report that the level of β-catenin is positively correlated to the degree of renal interstitial fibrosis (RIF). Protein phosphatase 2A (PP2A) binds to β-catenin and suppresses its phosphorylation, thereby increasing the total β-catenin expression. Additionally, NCTD dramatically elevates the level of phosphorylated β-catenin and decreases total β-catenin expression in a dose-dependent manner, consequently leading to the reduction of RIF. Mechanistically, PP2A-mediated suppression of β-catenin phosphorylation is an essential target for the anti-renal interstitial fibrotic effect of NCTD. Therefore, we report a potential theoretical basis for clinical application of NCTD in treating RIF.
科研通智能强力驱动
Strongly Powered by AbleSci AI